Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
According to the latest research, the global IVD Raw Materials market size was valued at USD 3542.75 million in 2022 and is expected to expand at a CAGR of 8.65% during the forecast period, reaching USD 5827.98 million by 2028.
IVDs are devices as defined in section 201(h) of the Federal Food, Drug, and Cosmetic Act, and may also be biological products subject to section 351 of the Public Health Service Act. Like other medical devices, IVDs are subject to premarket and postmarket controls. IVDs are generally also subject to categorization under the Clinical Laboratory Improvement Amendments (CLIA '88) of 1988.
In Vitro Diagnostic Products have additional labeling requirements, for In Vitro Diagnostic Products for Human Use. Before a manufacturer obtains marketing authorization for an IVD product, they must label the product in accordance with labeling regulations.
Influence of COVID-19 Outbreak on IVD Raw Materials Industry Development
People's awareness of in vitro diagnosis has been further improved, and the status of in vitro diagnosis has been significantly improved. After the outbreak of COVID-19, the primary task is to diagnose whether the patient is infected with the COVID-19 virus. Therefore, the status of in vitro diagnosis in hospitals has greatly increased, and the demand for IVD raw materials has also increased significantly with the support of epidemic prevention and control.
The demand for in vitro diagnostic products will increase due to the prevalence of COVID-19, mainly due to the rapid increase in market demand for rapid detection products such as PCR, NGS, and serology based on serology. The substantial increase in IVD demand has boosted the demand for IVD raw materials. Due to visible profits and a strong market, IVD raw material companies will accelerate the speed of product development. At the same time, market participants will also improve and enhance their current manufacturing and distribution capabilities, and focus on the commercialization and upgrade of products.
Strength
The increasing number of infectious diseases and chronic diseases has brought an increase in the demand for diagnosis.
The development of the IVD industry has led to a strong market demand for IVD raw materials.
Weakness
Manufacturers face greater risks of technology substitution and new product development.
Higher investment in R&D funds.
Opportunity
Increase in per capita disposable income, urbanization, population aging, increased health awareness, policy support, and technological progress.
Threat
The rise of local companies will intensify competition in the industry.
Increased instability in international trade.
Region Overview:
North America had the highest growth rate of all regions.
Company Overview:
Aalto Bio Reagents Ltd, Rockland Immunochemicals Inc., Creative Diagnostics,Technopath Clinical Diagnostics and Merck KGaA are the five key players in the global IVD Raw Materials market. These companies have shown consistent growth in revenue, larger volumes of sales and a prominent presence in terms of share in the global IVD Raw Materials market in the past 5 years.
Roche Diagnostics International Ltd develops and manufactures medical and diagnostic products. The Company produces self-monitoring systems, applications, testing, coagulation, and instruments for critical-care, cardiovascular, liver diseases, cancer, and tuberculosis. Roche Diagnostics markets its products worldwide.
Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
Segmentation Overview:
As for product types, the Antibodies segment held the largest market share in 2021.
Application Overview:
By application, the Pharmaceutical Company segment occupied the biggest share from 2017 to 2022.
This report elaborates on the market size, market characteristics, and market growth of the IVD Raw Materials industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of IVD Raw Materials. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global IVD Raw Materials Market Report Include:
Market Size Estimates: IVD Raw Materials market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: IVD Raw Materials market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the IVD Raw Materials market
Segment Market Analysis: IVD Raw Materials market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: IVD Raw Materials market situations and prospects in major and top regions and countries
IVD Raw Materials Market
IVD Raw Materials Industry Chain: IVD Raw Materials market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
IVD Raw Materials Industry News, Policies by regions
IVD Raw Materials Industry Porters Five Forces Analysis
Key players in the global IVD Raw Materials market are covered in Chapter 2:
VirionSerion GmbH
PRAHAS Healthcare
Rockland Immunochemicals Inc.
Merck KGaA
Roche Diagnostics International Ltd
Meridian
Creative Diagnostics
Aalto Bio Reagents Ltd
Medix Biochemica
Zoonbio Biotechnology Co., Ltd
OYC Europe
Hytest
Technopath Clinical Diagnostics
Thermo Fisher Scientific
Fapon Biotech Inc.
Cusabio Technology LLC
In Chapter 6 and Chapter 9, on the basis of types, the IVD Raw Materials market from 2018 to 2028 is primarily split into:
Antibodies
Enzyme
Proteins
Antigens
Viruses
Others
In Chapter 7 and Chapter 10, on the basis of applications, the IVD Raw Materials market from 2018 to 2028 covers:
Pharmaceutical Company
Laboratories
Hospitals
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global IVD Raw Materials market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the IVD Raw Materials industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of IVD Raw Materials market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the IVD Raw Materials industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on IVD Raw Materials market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the IVD Raw Materials market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed IVD Raw Materials market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
IVDs are devices as defined in section 201(h) of the Federal Food, Drug, and Cosmetic Act, and may also be biological products subject to section 351 of the Public Health Service Act. Like other medical devices, IVDs are subject to premarket and postmarket controls. IVDs are generally also subject to categorization under the Clinical Laboratory Improvement Amendments (CLIA '88) of 1988.
In Vitro Diagnostic Products have additional labeling requirements, for In Vitro Diagnostic Products for Human Use. Before a manufacturer obtains marketing authorization for an IVD product, they must label the product in accordance with labeling regulations.
Influence of COVID-19 Outbreak on IVD Raw Materials Industry Development
People's awareness of in vitro diagnosis has been further improved, and the status of in vitro diagnosis has been significantly improved. After the outbreak of COVID-19, the primary task is to diagnose whether the patient is infected with the COVID-19 virus. Therefore, the status of in vitro diagnosis in hospitals has greatly increased, and the demand for IVD raw materials has also increased significantly with the support of epidemic prevention and control.
The demand for in vitro diagnostic products will increase due to the prevalence of COVID-19, mainly due to the rapid increase in market demand for rapid detection products such as PCR, NGS, and serology based on serology. The substantial increase in IVD demand has boosted the demand for IVD raw materials. Due to visible profits and a strong market, IVD raw material companies will accelerate the speed of product development. At the same time, market participants will also improve and enhance their current manufacturing and distribution capabilities, and focus on the commercialization and upgrade of products.
Strength
The increasing number of infectious diseases and chronic diseases has brought an increase in the demand for diagnosis.
The development of the IVD industry has led to a strong market demand for IVD raw materials.
Weakness
Manufacturers face greater risks of technology substitution and new product development.
Higher investment in R&D funds.
Opportunity
Increase in per capita disposable income, urbanization, population aging, increased health awareness, policy support, and technological progress.
Threat
The rise of local companies will intensify competition in the industry.
Increased instability in international trade.
Region Overview:
North America had the highest growth rate of all regions.
Company Overview:
Aalto Bio Reagents Ltd, Rockland Immunochemicals Inc., Creative Diagnostics,Technopath Clinical Diagnostics and Merck KGaA are the five key players in the global IVD Raw Materials market. These companies have shown consistent growth in revenue, larger volumes of sales and a prominent presence in terms of share in the global IVD Raw Materials market in the past 5 years.
Roche Diagnostics International Ltd develops and manufactures medical and diagnostic products. The Company produces self-monitoring systems, applications, testing, coagulation, and instruments for critical-care, cardiovascular, liver diseases, cancer, and tuberculosis. Roche Diagnostics markets its products worldwide.
Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
Segmentation Overview:
As for product types, the Antibodies segment held the largest market share in 2021.
Application Overview:
By application, the Pharmaceutical Company segment occupied the biggest share from 2017 to 2022.
This report elaborates on the market size, market characteristics, and market growth of the IVD Raw Materials industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of IVD Raw Materials. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global IVD Raw Materials Market Report Include:
Market Size Estimates: IVD Raw Materials market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: IVD Raw Materials market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the IVD Raw Materials market
Segment Market Analysis: IVD Raw Materials market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: IVD Raw Materials market situations and prospects in major and top regions and countries
IVD Raw Materials Market
Competitive Landscape
and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product/service profile and recent development/updates, etc.IVD Raw Materials Industry Chain: IVD Raw Materials market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
IVD Raw Materials Industry News, Policies by regions
IVD Raw Materials Industry Porters Five Forces Analysis
Key players in the global IVD Raw Materials market are covered in Chapter 2:
VirionSerion GmbH
PRAHAS Healthcare
Rockland Immunochemicals Inc.
Merck KGaA
Roche Diagnostics International Ltd
Meridian
Creative Diagnostics
Aalto Bio Reagents Ltd
Medix Biochemica
Zoonbio Biotechnology Co., Ltd
OYC Europe
Hytest
Technopath Clinical Diagnostics
Thermo Fisher Scientific
Fapon Biotech Inc.
Cusabio Technology LLC
In Chapter 6 and Chapter 9, on the basis of types, the IVD Raw Materials market from 2018 to 2028 is primarily split into:
Antibodies
Enzyme
Proteins
Antigens
Viruses
Others
In Chapter 7 and Chapter 10, on the basis of applications, the IVD Raw Materials market from 2018 to 2028 covers:
Pharmaceutical Company
Laboratories
Hospitals
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global IVD Raw Materials market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the IVD Raw Materials industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of IVD Raw Materials market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the IVD Raw Materials industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on IVD Raw Materials market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the IVD Raw Materials market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed IVD Raw Materials market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
Years considered for this report:
Historical Years:
2018-2022Base Year:
2022Estimated Year:
2023Forecast Period:
2023-2028Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects...
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects including drivers, restraints...
